MatthewBHarmsMD

Neuromuscular Medicine, Neurophysiology

Associate Professor

Overview of Dr. Harms

Dr. Matthew Harms is a neurologist in New York, NY and is affiliated with multiple hospitals in the area, including New York-Presbyterian Hospital and NewYork-Presbyterian/Columbia University Irving Medical Center. He received his medical degree from University of California (San Francisco) School of Medicine and has been in practice 14 years. Dr. Harms accepts several types of health insurance, listed below. He is one of 482 doctors at New York-Presbyterian Hospital and one of 212 doctors at NewYork-Presbyterian/Columbia University Irving Medical Center who specialize in Neurology. He has more than 80 publications and over 500 citings.

Office
710 West 168th Street
New York, NY 10032
Book by Phone+1(928) 325-1588

Education & Training

Washington University/B-JH/SLCH ConsortiumFellowship, Clinical Neurophysiology, 2007 - 2008
University of California (San Francisco)Internship, Internal Medicine, 2003 - 2004
University of California San Francisco School of MedicineClass of 2003

Certifications & Licensure

FL State Medical License 2021 - Present
NY State Medical License 2015 - 2026
NJ State Medical License 2022 - 2025
MO State Medical License 2007 - 2016
CA State Medical License 2005 - 2010
American Board of Psychiatry and Neurology Neurology
American Board of Psychiatry and Neurology Neuromuscular Medicine

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2012

Clinical Trials

An Intermediate Size Expanded Access Protocol of AMX0035 for ALS
Approved for marketing
Roles: Contact

Publications & Presentations

PubMed

1 citations
Access for ALL in ALS: A large-scale, inclusive, collaborative consortium to unlock the molecular and genetic mechanisms of amyotrophic lateral sclerosis.
James D Berry, Sabrina Paganoni, Matthew B Harms, Neil Shneider, Jinsy Andrews
Muscle & Nerve. 2024-12-01
Body mass index is lower in asymptomaticexpansion carriers but not inpathogenic variant carriers compared to gene negatives.
Ikjae Lee, Mark A Garret, Joanne Wuu, Elizabeth A Harrington, James D Berry
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration. 2024-11-01
The Answer ALS return of results study: Answering the duty to disclose.
Jennifer Roggenbuck, Mackenzie Kaschalk, Rory Eustace, Leah Vicini, Yevgeniya Gokun
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration. 2024-11-01

Press Mentions

Variety of Advocacy, Fundraising Events Mark ALS Awareness MonthMay 4th, 2021
Lithium Boosts Muscle Strength in Mice with Rare Muscular DystrophyJune 3rd, 2019
The New Study Brings Good News for the People with Limb-Girdle Muscular DystrophyApril 22nd, 2019
Join now to see all

Insurance Accepted

Aetna Choice POS II
Aetna HMO
Anthem Blue Access Choice PPO
Anthem Blue Access PPO
BCBS Blue Card PPO
BCBS California PPO
BCBS Illinois PPO
Blue Shield California PPO
CIGNA HMO
CIGNA Open Access
CIGNA PPO
Great West PPO
Health Net California Large Group PPO
HealthLink PPO
Humana ChoiceCare Network PPO
Multiplan PHCS PPO
Multiplan PPO
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO
Please verify your coverage with the provider's office directly when scheduling an appointment